Novartis Pharmaceuticals has changed the dosage recommendations for its Migranal (dihydroergotamine mesylate) nasal spray. The maximum dosage allowed within 24 hours is now 2mg (four sprays) and the maximum weekly dose is 8mg (16 sprays).
